PURPOSE: Acceptability and uptake of cancer preventive interventions is associated with physician recommendation, which is dependent on physician familiarity with available preventive options. The goal of this study is to evaluate cancer prevention perceptions, understanding of breast and ovarian cancer risk factors, and prescribing behaviors of primary care physicians. METHODS: We conducted cross-sectional. Web-based survey of 750 primary care physicians (250 each for obstetrics/gynecology, internal medicine, and family medicine) in the United States. Survey respondents were recruited from an opt-in health care provider panel. RESULTS: Perception of importance and the practice of recommending general and cancer-specific preventive screenings and interventions significantly differed by provider type. These perceptions and behaviors reflected the demographics of the population that the primary care physicians see within their respective practices. The majority of respondents recognized genetic/hereditary risk factors for breast or ovarian cancer, while epidemiologic or clinical risk factors were less frequently recognized. Prescribing behaviors were related to familiarity with the interventions, with physicians indicating that they more frequently reinforced a specialist's recommendation rather than prescribed a preventive intervention. CONCLUSIONS: Cancer prevention perceptions, recognition of cancer risk factors, and prescribing behaviors differ among practice types and were related to familiarity with preventive options. Cancer prevention education and risk assessment resources should be more widely available to primary care physicians. Published by Elsevier Inc.
PURPOSE: Acceptability and uptake of cancer preventive interventions is associated with physician recommendation, which is dependent on physician familiarity with available preventive options. The goal of this study is to evaluate cancer prevention perceptions, understanding of breast and ovarian cancer risk factors, and prescribing behaviors of primary care physicians. METHODS: We conducted cross-sectional. Web-based survey of 750 primary care physicians (250 each for obstetrics/gynecology, internal medicine, and family medicine) in the United States. Survey respondents were recruited from an opt-in health care provider panel. RESULTS: Perception of importance and the practice of recommending general and cancer-specific preventive screenings and interventions significantly differed by provider type. These perceptions and behaviors reflected the demographics of the population that the primary care physicians see within their respective practices. The majority of respondents recognized genetic/hereditary risk factors for breast or ovarian cancer, while epidemiologic or clinical risk factors were less frequently recognized. Prescribing behaviors were related to familiarity with the interventions, with physicians indicating that they more frequently reinforced a specialist's recommendation rather than prescribed a preventive intervention. CONCLUSIONS:Cancer prevention perceptions, recognition of cancer risk factors, and prescribing behaviors differ among practice types and were related to familiarity with preventive options. Cancer prevention education and risk assessment resources should be more widely available to primary care physicians. Published by Elsevier Inc.
Entities:
Keywords:
Cancer prevention; Primary care physicians; Survey
Authors: Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener Journal: Am J Public Health Date: 2003-04 Impact factor: 9.308
Authors: Laura L Reimers; Parijatham S Sivasubramanian; Dawn Hershman; Mary Beth Terry; Heather Greenlee; Julie Campbell; Kevin Kalinsky; Matthew Maurer; Ramona Jayasena; Rossy Sandoval; Maria Alvarez; Katherine D Crew Journal: Breast J Date: 2015-04-16 Impact factor: 2.431
Authors: Goli Samimi; Brandy M Heckman-Stoddard; Shelley S Kay; Bonny Bloodgood; Kisha I Coa; Jennifer L Robinson; Bethany Tennant; Leslie G Ford; Eva Szabo; Lori Minasian Journal: Cancer Prev Res (Phila) Date: 2019-03-01
Authors: Christine Holmberg; Hanna Bandos; Angela Fagerlin; Therese B Bevers; Tracy A Battaglia; D Lawrence Wickerham; Worta J McCaskill-Stevens Journal: Cancer Prev Res (Phila) Date: 2017-10-04
Authors: S G Smith; I Sestak; A Forster; A Partridge; L Side; M S Wolf; R Horne; J Wardle; J Cuzick Journal: Ann Oncol Date: 2015-12-08 Impact factor: 32.976
Authors: Melissa L Harry; Ella A Chrenka; Laura A Freitag; Daniel M Saman; Clayton I Allen; Stephen E Asche; Anjali R Truitt; Heidi L Ekstrom; Patrick J O'Connor; Jo Ann M Sperl-Hillen; Jeanette Y Ziegenfuss; Thomas E Elliott Journal: BMC Health Serv Res Date: 2022-01-06 Impact factor: 2.655
Authors: Melissa L Harry; Stephen E Asche; Laura A Freitag; JoAnn M Sperl-Hillen; Daniel M Saman; Heidi L Ekstrom; Ella A Chrenka; Anjali R Truitt; Clayton I Allen; Patrick J O'Connor; Steven P Dehmer; Joseph A Bianco; Thomas E Elliott Journal: Hum Vaccin Immunother Date: 2022-03-18 Impact factor: 4.526
Authors: Goli Samimi; Brandy M Heckman-Stoddard; Christine Holmberg; Bethany Tennant; Bonny Bloodgood Sheppard; Kisha I Coa; Shelley S Kay; Leslie G Ford; Eva Szabo; Lori M Minasian Journal: Cancer Prev Res (Phila) Date: 2020-10-06